Sas Drug Development
Approved changes feed: RSS · Atom
cpe:2.3:a:sas:sas_drug_development:*:*:*:*:*:*:*:*
part: a version: * update: *
| Vendor | Sas (92141fd0-1bae-5599-a81e-a7636e003c39) |
|---|---|
| Product | Sas Drug Development (789b6c38-6b70-5e49-9b21-236b0ca54ec1) |
| Edition | * |
| Language | * |
| Software edition | * |
| Target software | * |
| Target hardware | * |
| Other | * |
| Notes | Imported from gcve-enriched-dumps CVE data |
PURL mappings
| PURL | Source | Last updated |
|---|---|---|
| No PURL mappings for this CPE yet. | ||
Vulnerability references
| Identifier | cpeApplicability | Submitted | db.gcve.eu details | Rationale |
|---|---|---|---|---|
CVE:CVE-2007-6763 |
vulnerable | 2026-06-03 14:28:30.661784 |
Details available
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
Published: 2019-07-31T17:08:43.000Z
Updated: 2024-08-07T16:18:20.755Z |
Imported from gcve-enriched-dumps CVE data |
Contribute
You can submit an edit proposal for this CPE entry or suggest a related product/vendor addition using the action button above.